Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain

Endocrinology

Volumn 142, Issue 6, 2001, Pages 2686-2694

  Karssen, A M ^a   Meijer, O C ^a   Van Der Sandt, I C J ^a   Lucassen, P J ^b   De Lange, E C M ^a   De Boer, A G ^a   De Kloet, E R ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CORTICOSTERONE; GLYCOPROTEIN P; HYDROCORTISONE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN TISSUE; CONTROLLED STUDY; GENETIC TRANSFECTION; GENOTYPE; HORMONE TRANSPORT; HOST CELL; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035017246     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.6.8213     Document Type: Article

References (54)

1. 1. McEwen BS, Weiss JM, Schwartz LS 1968 Selective retention of corticosterone by limbic structures in rat brain. Nature 220:911-912
2. 2. McMurry L, Hastings JW 1972 Rat brain binds adrenal steroid hormone: radioautography of hippocampus with corticosterone. Science 175:1133-1136
3. 3. De Kloet ER, Wallach G, McEwen BS 1975 Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology 96:598-609
4. 3H]aldosterone binding sites within mouse brain hippocampus. J Steroid Biochem 28:29-34
5. 5. Reul JM, De Kloet ER 1985 Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117: 2505-2511
6. 6. De Kloet ER, Van der Vies J, De Wied D 1974 The site of the suppressive action of dexamethasone on pituitary-adrenal activity. Endocrinology 94:61-73
7. 7. McEwen BS, De Kloet ER, Wallach G 1976 Interactions in vivo and in vitro of corticoids and progesterone with cell nuclei and soluble macromolecules from rat brain regions and pituitary. Brain Res 105:129-136
8. 3H-dexamethasone in the rat brain and pituitary. In: Stumpf WE, Grant L (eds) Anatomical Neuroendocrinology. S. Karger, Basel, pp 262-269
9. 9. Coutard M, Osbome-Pellegrin MJ, Funder JW 1978 Tissue distribution and specific binding of tritiated dexamethasone in vivo: autoradiographic and cell fractionation studies in the mouse. Endocrinology 103:1144-1152
10. 10. Meijer OC, De Lange ECM, Breimer DD, De Boer AG, Workel JO, De Kloet ER 1998 Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 139:1789-1793
11. 11. Schinkel AH, Wagenaar E, Van Deemter L, Mol CAAM, Borst P 1995 Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96:1698-1705
12. 12. Cordon-Cardo C, O'Brien JP, Casals D, Rittman GL, Biedler JL, Melamed MR, Bertino JR 1989 Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695-698
13. 13. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC 1989 Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem 37:159-164
14. 14. Jette L, Pouliot JF, Murphy GF, Béliveau R 1995 Isoform I (mdr3) is the major form of P-glycoprotein expressed in mouse brain capillaries. Evidence for cross-reactivity of antibody C219 with an unrelated protein. Biochem J 305:761-766
15. 15. Van de Vrie W, Marquet RL, Stoter G, De Bruijn EA, Eggermont AM 1998 In vivo model systems in P-glycoprotein-mediated multidrug resistance. Crit Rev Clin Lab Sci 35:1-57
16. 16. De Kloet ER 1991 Brain corticosteroid receptor balance and homeostatic control. Front. Neuroendocrinol 12:95-164
17. 17. De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M 1998 Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301
18. 18. Dallman MF, Akana SF, Scribner KA, Bradbury MJ, Walker CD, Strack AM, Cascio CS 1992 Stress, feedback and facilitation in the hypothalamopituitary-adrenal axis. J Neuroendocrinol 4:517-526
19. 19. Nishida S, Matsumura S, Horino M, Oyama H, Tenku A 1977 The variations of plasma corticosterone/cortisol ratios following ACTH stimulation or dexamethasone administration in normal men. J Clin Endocrinol Metab 45:585-588
20. 20. Underwood RH, Williams GH 1972 The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis. J Lab Clin Med 79:848-862
21. 21. West CD, Mahajan DK, Chavre VJ, Nabors CJ, Tyler FH 1973 Simultaneous measurement of multiple plasma steroids by radioimmunoassay demonstrating episodic secretion. J Clin Endocrinol Metab 36:1230-1236
22. 22. Kage A, Fenner A, Weber B, Schoneshofer M 1982 Diurnal and ultradian variations of plasma concentrations of eleven adrenal steroid hormones in human males. Klin Wochenschr 60:659-666
23. 23. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R 1992 Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 267:24248-24252
24. 24. Ravid R, Swaab DF, Van Zwieten EJ, Salehi A 1995 Controls are what make a brain bank go round. In: Cruz-Sanchez FF, Cuzner ML, Ravid R (eds) Neuropathological Diagnostic Criteria for Brain Banking, Biomedical and Health Research, vol 10. IOS Press, Amsterdam, pp 4-13
25. 25. Van der Hoeven RA, Hofte AJ, Frenay M, Irth H, Tjaden UR, Van der Greef J, Rudolphi A, Boos KS, Marko Varga G, Edholm LE 1997 Liquid chromatography-mass spectrometry with on-line solid-phase extraction by a restricted-access C18 precolumn for direct plasma and urine injection. J Chromatogr A 762:193-200
26. 26. Dantzig AH, Shepard RL, Law KL, Tabas L, Pratt S, Gillespie JS, Binkley SN, Kuhfeld MT, Starling JJ, Wrighton SA 1999 Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities. J Pharmacol Exp Ther 290:854-862
27. 27. Starling JJ, Shepard RL, Cao J, Law KL, Norman BH, Kroin JS, Ehlhardt WJ, Baughman TM, Winter MA, Bell MG, Shih C, Gruber J, Elmquist WF, Dantzig AH 1997 Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein. Adv Enzyme Regul 37:335-347
28. 28. Leckie C, Chapman KE, Edwards CR, Seckl JR 1995 LLC-PK1 cells model 11 β-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors. Endocrinology 136:5561-5569
29. 29. Pardridge WM, Mietus LJ 1979 Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J Clin Invest 64:145-154
30. 30. De Kloet ER, Veldhuis HD, Wagenaars JL, Bergink EW 1984 Relative binding affinity of steroids for the corticosterone receptor system in rat hippocampus. J Steroid Biochem 21:173-178
31. 31. Myles K, Funder JW 1994 Type I (mineralocorticoid) receptors in the guinea pig. Am J Physiol 267:E268-E272
32. 32. Horio M, Pastan I, Gottesman MM, Handler JS 1990 Transepithelial transport of vinblastine by kidney-derived cell lines. Application of a new kinetic model to estimate in situ Km of the pump. Biochim Biophys Acta 1027:116-122
33. 33. Decorti G, Peloso I, Favarin D, Klugmann FB, Candussio L, Crivellato E, Mallardi F, Baldini L 1998 Handling of doxorubicin by the LLC-PK1 kidney epithelial cell line. J Pharmacol Exp Ther 286:525-530
34. 34. Yang CP, DePinho SG, Greenberger LM, Arceci RJ, Horwitz SB 1989 Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J Biol Chem 264:782-788
35. 35. Gruol DJ, Bourgeois S 1994 Expression of the mdr1 P-glycoprotein gene: a mechanism of escape from glucocorticoid-induced apoptosis. Biochem Cell Biol 72:561-571
36. 36. Van Kalken CK, Broxterman HJ, Pinedo HM, Feller N, Dekker H, Lankelma J, Giaccone G 1993 Cortisol is transported by the multidrug resistance gene product P-glycoprotein. Br J Cancer 67:284-289
37. 37. Orlowski S, Mir LM, Belehradek J, Garrigos M 1996 Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem J 317:515-522
38. 38. Wolf DC, Horwitz SB 1992 P-glycoprotein transports corticosterone and is photoaffinity-labeled by the steroid. Int J Cancer 52:141-146
39. 39. Barnes KM, Dickstein B, Cutler GB, Fojo T, Bates SE 1996 Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells. Biochemistry 35:4820-4827
40. 40. Bourgeois S, Gruol DJ, Newby RF, Rajah FM 1993 Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis. Mol Endocrinol 7:840-851
41. 41. Schinkel AH, Smit JJ, Van Tellingen O, Beijnen JH, Wagenaar E, Van Deemter L, Mol CAAM, Van der Valk MA, Robanus Maandag EC, Te Riele HP, Berns AJM, Borst P 1994 Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502
42. 42. Gruol DJ, Vo QD, Zee MC 1999 Profound differences in the transport of steroids by two mouse P-glycoproteins. Biochem Pharmacol 58:1191-1199
43. 43. Karssen AM, Meijer OC, De Boer AG, Van der Sandt ICJ, De Lange ECM, De Kloet ER, The multidrug resistance 1a p-glycoprotein affects the penetration of glucocorticoids, except corticosterone, in the brain. Program of the 30th Annual Meeting Society for Neuroscience, New Orleans, LA, 2000, p 419 (Abstract 152.17)
44. 44. Seckl JR, Campbell JC, Edwards CR, Christie JE, Whalley LJ, Goodwin GM, Fink G 1990 Diurnal variation of plasma corticosterone in depression. Psychoneuroendocrinology 15:485-488
45. 45. Seckl JR 1997 11β-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action? Front Neuroendocrinol 18:49-99
46. 46. Gerlach JL, McEwen BS, Pfaff DW, Moskovitz S, Ferin M, Carmel PW, Zimmerman EA 1976 Cells in regions of rhesus monkey brain and pituitary retain radioactive estradiol, corticosterone and cortisol differentially. Brain Res 103:603-612
47. 47. Brooksbank BW, Brammall MA, Shaw DM 1973 Estimation of cortisol, cortisone and corticosterone in cerebral cortex, hypothalamus and other regions of the human brain after natural death and after death by suicide. Steroids Lipids Res 4:162-183
48. 48. Fazekas IG, Fazekas AT 1967 Corticosteroid fractions of the human brain. Endokrinologie 51:183-210
49. 49. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268-275
50. 50. Lombes M, Kenouch S, Souque A, Farman N, Rafestin-Oblin ME 1994 The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11 β-hydroxysteroid dehydrogenase. Endocrinology 135:834-840
51. 51. Sanchez MM, Young LJ, Plotsky PM, Insel TR 2000 Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci 20:4657-4668
52. 52. Joëls M, De Kloet ER 1994 Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog Neurobiol 43:1-36
53. 53. McEwen BS, Cameron H, Chao HM, Gould E, Magarinos AM, Watanabe Y, Woolley CS 1993 Adrenal steroids and plasticity of hippocampal neurons: toward an understanding of underlying cellular and molecular mechanisms. Cell Mol Neurobiol 13:457-482
54. 54. Oitzl MS, Van Haarst AD, De Kloet ER 1997 Behavioral and neuroendocrine responses controlled by the concerted action of central mineralocorticoid (MRS) and glucocorticoid receptors (GRS). Psychoneuroendocrinology [Suppl 1] 22:S87-S93